These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35495127)

  • 101. Dot1l cooperates with Npm1 to repress endogenous retrovirus MERVL in embryonic stem cells.
    Zhao X; Li X; Sun H; Zhao X; Gao T; Shi P; Chen F; Liu L; Lu X
    Nucleic Acids Res; 2023 Sep; 51(17):8970-8986. PubMed ID: 37522386
    [TBL] [Abstract][Full Text] [Related]  

  • 102. DOT-1.1 (DOT1L) deficiency in
    Liontis T; Verma K; Grishok A
    BBA Adv; 2023; 3():100080. PubMed ID: 37082252
    [TBL] [Abstract][Full Text] [Related]  

  • 103. DOT1L stimulates MYC/Mondo transcription factor activity by promoting its degradation cycle on chromatin.
    Sepulveda GP; Gushchanskaia ES; Mora-Martin A; Esse R; Nikorich I; Ceballos A; Kwan J; Blum BC; Dholiya P; Emili A; Perissi V; Cardamone MD; Grishok A
    bioRxiv; 2024 Feb; ():. PubMed ID: 38370658
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Neointima abating and endothelium preserving - An adventitia-localized nanoformulation to inhibit the epigenetic writer DOT1L.
    Shirasu T; Yodsanit N; Li J; Huang Y; Xie X; Tang R; Wang Q; Zhang M; Urabe G; Webb A; Wang Y; Wang X; Xie R; Wang B; Kent KC; Gong S; Guo LW
    Biomaterials; 2023 Oct; 301():122245. PubMed ID: 37467597
    [TBL] [Abstract][Full Text] [Related]  

  • 105. DOT1-like histone lysine methyltransferase is critical for adult vessel maintenance and functions.
    Lee H; Han DW; La H; Park C; Kang K; Kwon O; Uhm SJ; Song H; Do JT; Choi Y; Hong K
    Anim Biosci; 2024 Sep; 37(9):1635-1643. PubMed ID: 38665093
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Gain-of-function mutations in the catalytic domain of
    Zhang J; Yang T; Han M; Wang X; Yang W; Guo N; Ren Y; Cui W; Li S; Zhao Y; Zhai X; Jia L; Yang J; Wu C; Wang L
    Sci Adv; 2023 Jun; 9(22):eadc9273. PubMed ID: 37256945
    [TBL] [Abstract][Full Text] [Related]  

  • 107. A Review of Advanced Cutaneous Melanoma Therapies and Their Mechanisms, from Immunotherapies to Lysine Histone Methyl Transferase Inhibitors.
    de Oliveira Filho RS; de Oliveira DA; Nisimoto MM; Marti LC
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136297
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Tracking DOT1L methyltransferase activity by stable isotope labelling using a selective synthetic co-factor.
    Trainor N; Whitwell HJ; Jiménez B; Addison K; Leonidou E; DiMaggio PA; Fuchter MJ
    Commun Chem; 2024 Jun; 7(1):145. PubMed ID: 38937590
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs.
    Liao Q; Yang J; Ge S; Chai P; Fan J; Jia R
    J Pharm Anal; 2023 Feb; 13(2):127-141. PubMed ID: 36908859
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Prospect of targeting lysine methyltransferase NSD3 for tumor therapy.
    Li D; Tian T; Ko CN; Yang C
    Pharmacol Res; 2023 Aug; 194():106839. PubMed ID: 37400043
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Correction to: Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer.
    Yang L; Lei Q; Li L; Yang J; Dong Z; Cui H
    Clin Epigenetics; 2022 May; 14(1):67. PubMed ID: 35598003
    [No Abstract]   [Full Text] [Related]  

  • 112. The engagement of histone lysine methyltransferases with nucleosomes: structural basis, regulatory mechanisms, and therapeutic implications.
    Li Y; Ge K; Li T; Cai R; Chen Y
    Protein Cell; 2023 Apr; 14(3):165-179. PubMed ID: 37051671
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Common and distinct functions of mouse Dot1l in the regulation of endothelial transcriptome.
    Yoo H; La H; Park C; Yoo S; Lee H; Song H; Do JT; Choi Y; Hong K
    Front Cell Dev Biol; 2023; 11():1176115. PubMed ID: 37397258
    [TBL] [Abstract][Full Text] [Related]  

  • 114. H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets.
    Burlibasa L; Nicu AT; Chifiriuc MC; Medar C; Petrescu A; Jinga V; Stoica I
    Front Cell Dev Biol; 2023; 11():1181764. PubMed ID: 37228649
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Epigenetic modulators provide a path to understanding disease and therapeutic opportunity.
    Honer MA; Ferman BI; Gray ZH; Bondarenko EA; Whetstine JR
    Genes Dev; 2024 Jul; 38(11-12):473-503. PubMed ID: 38914477
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Research progress and applications of epigenetic biomarkers in cancer.
    Gao J; Shi W; Wang J; Guan C; Dong Q; Sheng J; Zou X; Xu Z; Ge Y; Yang C; Li J; Bao H; Zhong X; Cui Y
    Front Pharmacol; 2024; 15():1308309. PubMed ID: 38681199
    [TBL] [Abstract][Full Text] [Related]  

  • 117. The methyltransferase N6AMT1 participates in the cell cycle by regulating cyclin E levels.
    Mutso M; Brūmele B; Serova E; Väärtnõu F; Suija M; Kurg R
    PLoS One; 2024; 19(2):e0298884. PubMed ID: 38394175
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Beyond the tail: the consequence of context in histone post-translational modification and chromatin research.
    Weinzapfel EN; Fedder-Semmes KN; Sun ZW; Keogh MC
    Biochem J; 2024 Feb; 481(4):219-244. PubMed ID: 38353483
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Epigenetic (De)regulation in Prostate Cancer.
    Xu C; Zhao S; Cai L
    Cancer Treat Res; 2023; 190():321-360. PubMed ID: 38113006
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Genome-wide DNA methylation changes upon DOT1L inhibition in hormone-responsive breast cancer cells.
    Giurato G; Terenzi I; Chiuso F; Salvati A; Rizzo F; Tarallo R; Weisz A; Nassa G
    Front Cell Dev Biol; 2023; 11():1308025. PubMed ID: 38099289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.